{
    "elements": [
        {
            "type": "table",
            "sequence_num": 1,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "SAFE PRESCRIBING OF CHEMOTHERAPY IN PAEDIATRIC SERVICES POLICY"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21101"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff involved in the prescribing and screening of chemotherapy for children"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "29 June 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "28 June 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "POSCU, chemotherapy, paediatrics"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "Children's Cancer Measures, National Cancer Action Team."
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Division 9 - Pharmacy"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Deputy Chief Pharmacist"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "MSE Medicines Assurance Group E.Allen approval in lieu"
                    },
                    {
                        "text": "15 June 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Evelyn Allen"
                    },
                    {
                        "text": "Chief Pharmacist"
                    },
                    {
                        "text": "15 June 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "29 June 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "July 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 6,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Claire Fitzgerald"
                    },
                    {
                        "text": "Lead Paediatric Pharmacist -Broomfield"
                    },
                    {
                        "text": "28 May 2021"
                    },
                    {
                        "text": "Yaisha Patel"
                    },
                    {
                        "text": "Lead Paediatric Pharmacist - Basildon"
                    },
                    {
                        "text": "28 May 2021"
                    },
                    {
                        "text": "Alex Wan"
                    },
                    {
                        "text": "Lead Haematology Pharmacist Basildon"
                    },
                    {
                        "text": "28 May 2021"
                    },
                    {
                        "text": "Eva Tsouana"
                    },
                    {
                        "text": "Consultant Paediatrician - Basildon"
                    },
                    {
                        "text": "28 May 2021"
                    },
                    {
                        "text": "Paul Smith"
                    },
                    {
                        "text": "Clinical Lead Pharmacist - Southend"
                    },
                    {
                        "text": "14 June 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 3,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "MSE Medicines Assurance Group"
                    },
                    {
                        "text": "15 June 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Site Guidelines for the administration of cytotoxic drugs (or equivalent) Administration of medicines policy (or equivalent) Prescribing of medicines policy (or equivalent) MSEPO-21089 Vinca alkaloids policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Revie wer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Harmonised for MSE-wide use which replaces the following at Broomfield Hospital: 19010 Prescribing chemotherapy for children; new document for Southend and Basildon Hospitals."
                    },
                    {
                        "text": "29 June 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 6
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust ...................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Decision to treat and treatment plan ............................................................................. 6"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Authority to prescribe chemotherapy ............................................................................ 7"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Prescribing a cycle of chemotherapy ............................................................................ 7"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Training Requirements ................................................................................................. 8"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Monitoring and Audit ..................................................................................................... 8  Approval and Implementation ....................................................................................... 9  Equality impact assessment ......................................................................................... 9  References ................................................................................................................... 9 Appendix 1: Register of medical staff able to prescribe chemotherapy in children's services10 Appendix 2: Preliminary equality analysis .......................................................................... 11"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "This policy is intended to safeguard patients and staff by defining best practice for all disciplines involved in the delivery of anti-cancer cytotoxic chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Cytotoxic drugs are defined as all drugs with direct anti-tumour activity including conventional anticancer drugs, monoclonal antibodies, targeted treatments (e.g. Tyrosine Kinase Inhibitors) and drugs such as Thalidomide."
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Support the safe prescribing and screening of anti-cancer cytotoxic chemotherapy for children's services in MSE Trust;"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Guide staff delivering anti-cancer chemotherapy to paediatric patients with malignant disease. It does not deal with cytotoxic chemotherapy specifically for immunosuppressive purposes, or for the treatment of non-malignant disease but similar principles must apply."
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "type": "table",
            "sequence_num": 24,
            "data": {
                "num_rows": 9,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "PTC"
                    },
                    {
                        "text": "Primary Treatment Centre"
                    },
                    {
                        "text": "POSCU"
                    },
                    {
                        "text": "Paediatric Oncology Shared Care Unit"
                    },
                    {
                        "text": "CCLG"
                    },
                    {
                        "text": "Children's Cancer and Leukaemia Group"
                    },
                    {
                        "text": "CYPCNCG"
                    },
                    {
                        "text": "Children and Young Person Cancer Network Co-ordinating Group"
                    },
                    {
                        "text": "GOSH"
                    },
                    {
                        "text": "Great Ormond Street Hospital"
                    },
                    {
                        "text": "UCLH"
                    },
                    {
                        "text": "University College Hospital London"
                    },
                    {
                        "text": "MDT"
                    },
                    {
                        "text": "Multidisciplinary Team"
                    },
                    {
                        "text": "GCP"
                    },
                    {
                        "text": "Good Clinical Practice"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "MSE Patient Safety & Quality Group"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Receiving exception reports and taking action in response to issues raised from Medicines Assurance Group and/or department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "MSE Medicines Assurance Group"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the effective implementation, use and timely review of this policy;"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that monitoring arrangements are appropriately performed by the Site Medicines Optimisation and Safety Groups (MOSG);"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where necessary, escalating concerns to the Chief Nursing Officer, site Director of Nursing, Deputy Director of Nursing for Paediatrics or Chief Medical Officer, site Medical Director, Clinical Director for Paediatrics as appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exception reporting to the MSE Patient Safety & Quality Group on developments, concerns and progress concerning paediatric chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "Site Medicines Optimisation and Safety Group (MOSG)"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring this policy through incident reports;"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Escalating issues to site divisional governance groups and MAG as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "Chief Executive"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As the Trust's Accountable Officer has overall responsibility for ensuring the Trust has robust, complete and up to date documents in place to govern and guide activities so that legal and national requirements are met."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "Chief Medical Officer"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the site Medical Directors that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated paediatric chemotherapy issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Site Medical Directors & Clinical Director for Paediatrics"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appointing the Lead and Deputy Clinicians overseeing paediatric chemotherapy and agreeing their list of responsibilities;"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated paediatric chemotherapy issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Chief Nursing Officer"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the Deputy/ Chief Pharmacist that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated paediatric chemotherapy issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Site Director of Nursing & Deputy Director of Nursing for Paediatrics"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated paediatric chemotherapy issues involving professions they oversee are appropriately managed corporately;"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.9,
                "text": "Chief Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Setting the overall framework and policy standards for paediatric chemotherapy across the organisation, in line with regulatory and best practice guidance;"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring a monitoring process exists and functions for policy standard."
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "MSE Paediatric Oncology Multidisciplinary Team (MDT)"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing treatment support for all paediatric cancer patients diagnosed between the ages of 0-16 years;"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing systematic follow up of patients that have completed treatment"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Co-ordinating care between PTC and POSCU;"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Participating in network agreed audits to monitor implementation of local guidelines;"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that follow-up and investigation of paediatric chemotherapy incidents is completed in accordance with Trust policies for incident management (MSEPO- 19014 & 19015, and medication errors MSEPO-20206."
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.11,
                "text": "Lead Clinician (Consultant Paediatrician) as Head of POSCU Service and associate member of CCLG"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that all staff involved in delivering chemotherapy to children under the governance of the MDT have undertaken the agreed training;"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring chemotherapy prescriptions are written one week prior to clinic in conjunction with the deputy lead clinician, lead nurse and designated pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that follow-up and investigation of paediatric chemotherapy incidents is completed in accordance with Trust policies for incident management (MSEPO-"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19014 & 19015, and medication errors MSEPO-20206;"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Lead Clinician may delegate aspects of the role to the Deputy Lead Clinician (an Associate Specialist in Paediatrics with an interest in paediatric oncology), though overall responsibility remains with them."
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.12,
                "text": "Lead Nurse \u2013 Paediatric Oncology and Chemotherapy Trained Nurse;"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing professional leadership for nursing services for paediatric chemotherapy management."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.13,
                "text": "Designated Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the safe and effective provision of chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Decision to treat and treatment plan"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Following referral to the appropriate PTC the decision to treat a patient with chemotherapy should be made by a cancer specialist (consultant) at that centre."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "The patient should be discussed at an appropriate MDT, usually the paediatric oncology MDT."
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "All patients should have a treatment plan for each course of chemotherapy that they undergo. A copy of this treatment plan must be readily accessible to health professionals e.g. kept in the patient's local case notes."
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Authority to prescribe chemotherapy"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "Paediatric IntraTHECAL Chemotherapy must NEVER by prescribed / dispensed / administered in MSE Trust."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "The following healthcare professionals can be authorised to prescribe chemotherapy provided they have completed the CYPCNCG agreed training:"
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consultants"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All other doctors must NOT prescribe or transcribe parenteral or oral chemotherapy. A register of authorised prescribers is held by pharmacy (appendix 1)."
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Prescribing a cycle of chemotherapy"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Each cycle of chemotherapy, including supportive treatment, must be prescribed on a specific prescription chart. Always refer to the original treatment protocol when completing a chemotherapy prescription and take note if dose modifications are required because of age or previous toxicity."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "POSCU acceptable regimens"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 1,
                "text": "7.2.1  Chemotherapy  should  only  be  prescribed  if  the  regimen  is  on  the  CYPCNCG agreed list which is available in electronic form from the PTC."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.3,
                "text": "Prescription requirements:"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient's name, date of birth, unit number, consultant, allergies, current weight and body surface area;"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ward or department where drugs are to be given;"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Regime and week of treatment;"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Date;"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Approved drug name. If handwritten print clearly in full, using block capital letters, the names of all drugs prescribed. Never use abbreviations;"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Dose: ensure correct dose is calculated, referring to dose modification details in protocol;"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Route and method of administration clearly stated."
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Signed and dated by the prescriber;"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Include any other appropriate information if required to contribute to safe and effective medicine administration."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.4,
                "text": "Pharmacist screening"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.4.1  All cytotoxic prescriptions must be clinically screened by a suitably trained pharmacist prior to dispensing of parenteral and oral chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.5,
                "text": "Incident reporting"
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.1  All detected incidents must be reported on the Trust Incident Reporting system and managed in accordance with Trust policies for incident management (MSEPO- 19014 & 19015, and medication errors MSEPO-20206."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "CYPCNCG training:"
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medical staff that are competent to prescribe chemotherapy should have at least one year experience at a tertiary children's cancer centre/PTC or equivalent. They must attend an annual update from tertiary centre to update competencies."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Nursing staff attend structured chemotherapy training delivered by tertiary centres e.g. GOSH/UCLH- PTC. Chemo-work to be completed and signed off before nursing staff are declared competent to administer chemotherapy. There is a national chemo passport which can be transferred across Trusts from end of the year."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Good Clinical Practice (GCP) certificate which is updated every two years which the medical staff, nursing staff and pharmacy staff dealing with chemotherapy and trials should keep up to date."
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "type": "table",
            "sequence_num": 107,
            "data": {
                "num_rows": 3,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Prescribing safety"
                    },
                    {
                        "text": "Prescription check Incident reports"
                    },
                    {
                        "text": "Designated Pharmacist for Paediatric Oncology"
                    },
                    {
                        "text": "Weekly"
                    },
                    {
                        "text": "Paediatric Oncology MDT Site Medicines Optimisation & Safety Group"
                    },
                    {
                        "text": "Paediatric Specialty Governance Group. Medicines Assurance Group."
                    },
                    {
                        "text": "Prescription requirements are fulfilled"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "Designated Pharmacist for Paediatric Oncology"
                    },
                    {
                        "text": "Paediatric Oncology MDT"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "All policies, procedures and guidelines will be approved by Medicines Assurance Group, which is the specialist group with the authority to approve local medication documents. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "It is the author's responsibility to inform all prescribers, nursing and pharmacy of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Equality impact assessment"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 2)"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Children's Cancer Measures, Manual for Cancer Services Version 3.0 (2013), National Cancer Peer Review Programme, National Cancer Action Team"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Alder Hey Operational Policy for Dispensing of Chemotherapy"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Safe prescribing of chemotherapy in paediatric services policy / MSEPO-21101/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "type": "image",
            "sequence_num": 119,
            "data": {
                "url": "MSEPO-21101 Safe prescribing of chemotherapy in paediatric services policy 1.0.001.png"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Register of medical staff able to prescribe chemotherapy in children's services"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Copies of this register are kept in the following area(s):  Pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "type": "table",
            "sequence_num": 122,
            "data": {
                "num_rows": 5,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Grade"
                    },
                    {
                        "text": "Signature"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Safe prescribing of chemotherapy in paediatric services policy / MSEPO-21101/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix2: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Safe prescribing of chemotherapy in paediatric services (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "type": "table",
            "sequence_num": 127,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 128,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Harmonisation for Trust-wide use"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Harmonised documentation"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff and Patients have consistent processes applied for high risk medicine"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No \u2013 in line with national best practice and mandatory compliance"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 129,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Deputy Chief Pharmacist"
                    },
                    {
                        "text": "19 May 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Safe prescribing of chemotherapy in paediatric services policy / MSEPO-21101/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 131
        }
    ]
}